Biosearch Expands Licensing of Roche Patents to Manufacture Kits Targeting the in-vitro Diagnostic Industry
News Mar 10, 2010
Biosearch Technologies, Inc. has announced that the company has expanded its licenses from Roche Molecular Systems, Inc. (Roche). The expanded license grants Biosearch the right to manufacture and sell validated kits to the in-vitro diagnostic (IVD) marketplace as licensed products covered by multiple patents assigned to Roche. Kits sold to the IVD industry will comprise of probes, primers, enzymes, and any other essential reagents necessary to amplify and detect diagnostic targets.
Marc Beal, Director of Corporate Development at Biosearch Technologies, comments, “On September 16th, 2009, Biosearch took licenses to Roche patents covering practice of the 5’ Nuclease process, and later in the year, licensed the CDC patents describing the 2009 H1N1 and Influenza A Sub-typing signatures. With this expanded Roche license, Biosearch is poised to enter the IVD marketplace as a pivotal manufacturer of diagnostic kits.”
As the inventor and patent holder of the BHQ® (Black Hole Quencher®), CAL Fluor®, and Quasar® dye technologies, Biosearch is the sole source offering access to these proprietary dyes for research application.
Furthermore, Biosearch is the only company able to synthesize them into probes for incorporation into kits for diagnostic or commercial purposes. The series of BHQ dyes have become an essential component in the highest performing, frequently demanded qPCR assays in the IVD market, including the original 2009 H1N1 influenza assays purchased by public health and other qualified laboratories worldwide.
Gene Involved in Embryo Development Identified Using CRISPR/Cas9News
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development.READ MORE
New Method to Separate Mirrored Molecules Could Lead to Safer DrugsNews
The Dionne lab is developing an optical filter to sort chiral molecules, which could lead to purer and safer drugs and agrichemicals.READ MORE
APC Protein Deletion Disrupts Cell Signalling and Could Cause AutismNews
Researchers show deletion of the protein APC in progenitor cells leads to massive disruption of brain development and a signaling cascade previously linked to genes associated with autism.READ MORE